Product category:
Laboratory and scientific training and education
News Release from: Invitrogen | Subject: Science of Bioproduction workshop
Edited by the Laboratorytalk Editorial
Team on 12 March 2007
How to produce profitable
biopharmaceuticals
PD-Direct is holding a pre-conference workshop, the Science of Bioproduction, on Monday 23 April 2007 at Bioprocess International, Paris, France
This Invitrogen PD-Direct run workshop will provide advice on everything required to take a biotherapeutic from bench to production and will be ideal for scientists in biotech companies that are looking to take antibodies, recombinant proteins, viruses or cell therapies into clinical development, rapidly and cost-effectively The workshop, which is run by PD-Direct's Bryan Monroe, a bioprocess expert with many years experience in major pharma companies, will include insights from PD Direct's specialists, Dr Laurie Donahue-Hjelle and Peggy Lio, on vector construction, cell line development and media optimization, as well as invaluable product characterisation and scale-up information
This article was originally published on Laboratorytalk on 14 Sep 2005 at 8.00am (UK)
Related stories
Profiling service for immune response biomarkers
Provides researchers with a discovery method for rapid identification of biomarkers specific to disease states that result from altered immunoreactivity to self proteins
Laurie Donahue-Hjelle, director, cell line development for Invitrogen PD-Direct, stated: "Well thought out bioprocess development will lead to efficient timelines, quality product and low cost of goods and it is never too early in clinical development to implement this level of planning".
Donahue-Hjelle added: "By attending 'The Science of Bioproduction' workshop, scientists can tap into the many decades of expertise in process development and cell culture manufacturing the PD-Direct team has.
"They will learn about the bioprocess activities that are critical for reducing risk and saving time, which could help them avoid costly mistakes and result in producing highly profitable biotherapeutics.".
• Invitrogen: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
